The paradox playing out at Rocket Lab could hardly be starker. The company just delivered the fastest satellite launch in history – a 16-hour-and-42-minute sprint for the U.S. Space Force – yet its stock has been punished as if nothing happened. After a 6% slide on Monday and another 2.49% drop on Tuesday, shares now trade at €86.00, leaving them 29% lower over the past 30 days.
A Mission That Rewrote the Playbook
The VICTUS HAZE operation was a technical tour de force. Upon receiving the official go-ahead from the Space Force, Rocket Lab had its Electron rocket off the pad in New Zealand in under 17 hours – a full ten hours faster than the previous record set by the Victus-Nox mission. The company’s own Pioneer satellite, delivered as a turnkey solution, reached full operational capability after 37 hours and 36 minutes, comfortably inside the military’s 72-hour deadline. In orbit, the satellite is now simulating the interception of hostile missiles, cementing Rocket Lab’s role as a go-to partner for tactical responsive space.
Yet the market’s reaction was anything but celebratory.
A Perfect Storm of Sector Weakness and Insider Sales
The broader space sector has been in freefall. On Monday, SpaceX shares cratered 16% on reports of a multi-billion-dollar bond issuance and fears over the company’s escalating capital needs. The selling wave swept across the industry, dragging down Firefly Aerospace and Redwire by 6% to 9%. Rocket Lab, despite its independence, got caught in the undertow.
Compounding the external pressure is a notable insider retreat. Over the last 90 days, Rocket Lab executives have sold a net $38.5 million worth of shares. In mid-June, chief legal officer Arjun Kampani moved a million-dollar block into an exchange fund – a move that often signals a desire to diversify or lock in gains. While insider selling is not necessarily a bearish signal, the sheer scale has added to the negative sentiment.
Should investors sell immediately? Or is it worth buying Rocket Lab?
Operational Strength That Refuses to Quit
Against this messy backdrop, Rocket Lab’s underlying business is firing on all cylinders. First-quarter 2026 revenue hit a record $200.3 million, up 63.5% year-over-year, with gross margin also reaching an all-time high. The order backlog stands at a robust $2.2 billion, and management has guided for second-quarter revenue of between $225 million and $240 million.
Tangible contract wins continue to pile up. A $30 million deal with Anduril for HASTE launches and a separate Defense Department award covering 20 launches worth $190 million underscore the company’s deepening ties with the military. Meanwhile, development of the Neutron rocket is advancing, with engine tests underway and a first flight targeted for 2026.
Technical Support Levels Come Into Focus
The recent sell-off has pushed Rocket Lab’s relative strength index to 41.9, inching toward oversold territory. The stock now sits 35% below its 52-week high of €133.80. One crucial floor is the 100-day moving average at €76.27 – a level that has so far held during the current rout. Whether that support line holds will depend largely on whether the sector-wide pessimism begins to lift.
For now, Rocket Lab finds itself trapped between a record-breaking operational narrative and a punishing market environment. The numbers say the business has rarely looked stronger. The charts say investors are not yet ready to believe.
Ad
Rocket Lab Stock: Buy or Sell?! New Rocket Lab Analysis from June 23 delivers the answer:
The latest Rocket Lab figures speak for themselves: Urgent action needed for Rocket Lab investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 23.
Rocket Lab: Buy or sell? Read more here...









